REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 418.10
Bid: 418.00
Ask: 418.20
Change: 0.00 (0.00%)
Spread: 0.20 (0.048%)
Open: 416.80
High: 420.20
Low: 416.80
Prev. Close: 418.10
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Multi Country Contract with Rentokil

20 Jul 2011 07:00

RNS Number : 6939K
Byotrol PLC
20 July 2011
 



 20 July 2011

 

 

Byotrol plc

Four Year, Multi Country, Multi Product agreement

with Rentokil Initial plc

 

 

Byotrol plc ('Byotrol'), the developer of anti microbial hygiene technologies, is delighted to announce that it has signed a potentially multi-million pound contract, with Rentokil Initial plc ('Rentokil'). The four year contract covers multiple countries and a range of products.

 

This potentially transformational deal represents a landmark commercial milestone for Byotrol. The Byotrol technology will be adopted by the Initial Hygiene division ('Initial') of Rentokil, one of the largest business services companies in the world, providing hygiene services to a range of clients including Government, health and education and commercial organisations.

 

The contract is for the supply of hand hygiene and surface sanitisation products for use in Initial's service offering to washrooms and kitchens across 16 European countries. This contract confirms Byotrol's unique anti microbial technology as the innovation of choice for companies looking to the next generation of hygiene solution.

 

The products and services based on the Byotrol technology platform will be rolled out by Initial starting in Q4 2011, and will see Byotrol positioned as an important ingredient within Initial's hand hygiene product portfolio.

 

Commenting on the contract, Gary Millar, CEO of Byotrol, said:

 

"Our strategy of working with specialist service suppliers and distributors is borne out by this significant contract. The endorsement of the Byotrol technology by the Initial Hygiene division of Rentokil is tremendously exciting, and will transform the way Byotrol's technology is recognised in the hygiene industry. Additionally, Rentokil's ability to deploy the technology into wider markets will significantly extend the number of those brought into contact with Byotrol."

Peter Slator, Business Manager, Rentokil's Initial Hygiene business unit, added:

 

"Our new range of surface and hand hygiene products, powered by Byotrol's unique technology, will be a valuable element in achieving Initial's objective of 'Raising Hygiene Standards' throughout our customers' organisations. With its gentle, yet powerful, formulation and its long lasting antimicrobial properties, it will give our customers access to a pioneering hygiene solution and enable us to penetrate new markets."

 

 

Enquiries:

 

Byotrol plc 01925 742 000

Gary Millar, Chief Executive

Richard Bell, Finance Director

 

Arbuthnot Securities 020 7012 2000

Nominated Adviser and broker

Antonio Bossi / Henry Willcocks

 

Winningtons 020 3176 4722

Tom Cooper / Paul Vann 0797 122 1972

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a standalone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTMMGMNLLVGMZM
Date   Source Headline
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.